Cargando…
Convalescent Plasma for the Treatment of Severe COVID-19
The COVID-19 pandemic in 2020 is one of the worst catastrophic events in human history. Several non-specific antiviral drugs have been tried to defeat the SARS-CoV-2, with mixed results. Convalescent plasma from patients who have recovered from COVID-19 is one of the specific biologic therapies bein...
Autores principales: | Franchini, Massimo, Liumbruno, Giancarlo Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871873/ https://www.ncbi.nlm.nih.gov/pubmed/33574654 http://dx.doi.org/10.2147/BTT.S272063 |
Ejemplares similares
-
The Three Pillars of COVID-19 Convalescent Plasma Therapy
por: Franchini, Massimo, et al.
Publicado: (2021) -
Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022) -
Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021) -
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience
por: Liumbruno, Giancarlo Maria, et al.
Publicado: (2014) -
How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)